Expression of functional markers in acute lymphoblastic leukemia

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Acute lymphoblastic leukemia (ALL) is a significant hematologic malignancy.
• Understanding molecular markers associated with ALL prognosis is crucial for effective treatment strategies.

Purpose of the Study:

• To investigate the association between specific surface antigens, multidrug resistance (MDR) parameters, tissue infiltration markers, colony-stimulating factor receptors, and cell cycle markers with clinical outcomes in ALL patients.
• To identify key predictive markers for the clinical behavior of ALL.

Main Methods:

• Analysis of surface antigens, MDR parameters (P-glycoprotein [PGP], multidrug resistance-associated protein [MRP], lung resistance-related protein [LRP]), tissue infiltration parameters (CD18, CD44, VCAM, MMP2), colony-stimulating factor receptors (G-CSFr, GM-CSFr), and cell cycle markers (Ki-67, topoisomerase IIalpha) in 86 ALL patients.
• Correlation analysis to determine relationships between marker expression and clinical parameters.

Main Results:

• Lung resistance-related protein (LRP), P-glycoprotein (PGP), and CD18 expression were significantly associated with poor clinical outcomes in ALL.
• LRP expression demonstrated correlations with CD18, CD44, and G-CSFr.
• Increased Ki-67 fraction was observed in ALL patients with hepato-splenomegaly and extramedullary involvement.

Conclusions:

• The analysis of LRP, PGP, CD18, and Ki-67 holds potential for predicting the clinical behavior of acute lymphoblastic leukemia.
• These markers may serve as valuable prognostic indicators in ALL management.